Konovo Hires CFO with Focus on Innovation

Healthcare intelligence specialist Konovo has hired Tim Albury, a veteran of the financial operations of healthcare and life science technology companies, as Chief Financial Officer.

Konovo was formed a month ago from the merger of the three healthcare research firms within Apollo Intelligence - InCrowd, SHG and GlocalMind. The Boston, MA-based real-time life sciences and healthcare insights group operates across thirteen countries in the Americas, Europe and Asia, and is a portfolio company of Frazier Healthcare Partners. The company combines a global panel of healthcare professionals and patients with mobile-first quant and qual research capabilities, plus AI-based capabilities to streamline and integrate the gathering and sharing of insights.

Albury (pictured) brings more than 35 years of experience from private and public companies, most recently as CFO of AQuity Solutions, which he guided from early years through to its sale to healthcare enablement firm IKS Health. Earlier he held CFO roles at oncology solutions and services firm ConcertAI; medical imaging and e-Clinical company CALYX; cardiopulmonary therapies developer Liquidia Technologies; and drug delivery and manufacture firm Osmotica Pharmaceuticals. His experience includes private equity, mergers & acquisitions, and earnings optimization, and he holds a Master's degree in professional accountancy from the University of Miami, and a Bachelor's in Accounting from Liberty University.

Konovo CEO Tal Rosenberg comments: 'Tim Albury has proven that savvy financial operations are an engine of innovation that can propel the success of technology companies. We are eager to apply his guidance at Konovo as we expand our AI-native intelligent platform to address longstanding market research industry challenges - connecting fragmented data so that healthcare and life science companies can gain faster access to deeper, actionable insights.'

The firm is online at www.konovo.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.